Download PDF

1. Company Snapshot

1.a. Company Description

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry.It operates in two segments, Clear Aligner; and Scanners and Services.The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth.


This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment.The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers.This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan.


The company sells its products in the United States, Switzerland, China, and internationally.Align Technology, Inc.was incorporated in 1997 and is headquartered in Tempe, Arizona.

Show Full description

1.b. Last Insights on ALGN

Align Technology's recent performance was positively driven by its Q3 earnings and revenue beat, with quarterly earnings of $2.61 per share, surpassing the Zacks Consensus Estimate of $2.37 per share. The company's steady Clear Aligner demand and scanner upgrades are expected to shape its performance. Additionally, institutional investors such as Creative Planning and Coldstream Capital Management Inc. have grown their positions in the company, with increases of 15.6% and 22.0%, respectively. Analysts have set a price target of $175.45, with a "Hold" rating from sixteen brokerages.

1.c. Company Highlights

2. Align Technology's Q3 2025 Earnings: A Mixed Bag

Align Technology reported total revenues of $996 million for Q3 2025, a 1.8% year-over-year increase, with Clear Aligner volumes up 5% to 648,000 cases. Non-GAAP operating margin was 23.9%, exceeding the company's outlook of approximately 22%. The company's non-GAAP net income per diluted share was $2.61, up $0.11 sequentially and up $0.26 year-over-year, beating analyst estimates of $2.37. Gross margin for the quarter was 64.2%, down 5.7 points sequentially and 5.5 points year-over-year, while non-GAAP gross margin was 70.4%, relatively flat year-over-year.

Publication Date: Oct -31

📋 Highlights
  • Total Revenue Growth:: Q3 revenue reached $996 million, reflecting a 1.8% year-over-year increase, with Clear Aligner volumes up 5% to 648,000 cases.
  • Non-GAAP Operating Margin:: Operating margin hit 23.9%, surpassing the 22% forecast, driven by efficient cost management and demand initiatives.
  • Regional Growth Drivers:: EMEA and APAC regions led Clear Aligner volume growth, with APAC and Latin America showing strong sequential gains.
  • Product Innovation Impact:: New iTero features (AI X-ray, personalized visualization) and exocad ART pilots signal expanded digital workflow capabilities.
  • Financial Guidance:: Q4 revenue projected at $1.025–1.045 billion, with non-GAAP gross margin expected to stabilize at ~71% despite GAAP margin declines.

Segment Performance

Clear Aligner revenues increased 2.4% year-over-year, driven by growth in EMEA and APAC regions, as well as strong sequential growth from APAC and Latin American regions. Invisalign First and Invisalign Palatal Expander continued to drive growth year-over-year across all regions. Systems and Services revenues were $189.9 million, down 8.6% sequentially and 0.6% year-over-year. The company's iTero Digital Solutions segment saw new product innovations, including AI-enabled X-ray assessment and dynamic personalized visualization.

Guidance and Outlook

The company expects Q4 2025 worldwide revenues to be in the range of $1.025 billion to $1.045 billion, up sequentially from Q3. For fiscal 2025, the company expects Clear Aligner volume growth to be mid-single digits and revenue growth to be flat to slightly up from 2024. The company's guidance implies a continued strong performance in the Clear Aligner segment, as well as expansion of digital scanning solutions.

Valuation

At current prices, Align Technology trades at a P/E Ratio of 26.48, P/B Ratio of 2.53, and EV/EBITDA of 13.22. These valuation multiples suggest that the market is pricing in a certain level of growth and profitability for the company. With analysts estimating next year's revenue growth at 3.2%, it remains to be seen whether the company can meet or exceed these expectations.

Operational Highlights

The company highlighted the strength of its DSO partnerships, with about 25% of its business attributed to DSOs. The company's partnership with HFD is also paying off, with more doctors using it to help patients with financing. Joseph Hogan noted that DSOs are using algorithms to drive growth in specific segments within dental, and that the company's growth is due to DSOs' ability to offer competitive pricing and financing options.

3. NewsRoom

Card image cap

Fisher Asset Management LLC Sells 4,660 Shares of Align Technology, Inc. $ALGN

Dec -04

Card image cap

Align Technology, Inc. (ALGN) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec -03

Card image cap

Align Technology, Inc. (ALGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Dec -02

Card image cap

Financial Survey: Align Technology (NASDAQ:ALGN) & Straumann (OTCMKTS:SAUHY)

Dec -01

Card image cap

Financial Survey: McKesson (NYSE:MCK) vs. Align Technology (NASDAQ:ALGN)

Dec -01

Card image cap

Coldstream Capital Management Inc. Acquires 402 Shares of Align Technology, Inc. $ALGN

Nov -28

Card image cap

Align Technology Recognized for the 3rd Time in Extel's 2025 All-America Executive Team Rankings, Including the Most Honored Company Distinction

Nov -26

Card image cap

Creative Planning Grows Position in Align Technology, Inc. $ALGN

Nov -25

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (7.66%)

6. Segments

Clear Aligner

Expected Growth: 8%

Align Technology's Clear Aligner growth is driven by increasing adoption in orthodontics and dentistry, expanding into new markets, and rising demand for aesthetic and convenient teeth straightening solutions. Additionally, the company's investments in digital marketing, sales force expansion, and strategic partnerships contribute to its growth.

Systems and Services

Expected Growth: 6%

Align Technology's Systems and Services segment growth is driven by increasing adoption of digital orthodontics, rising demand for Invisalign clear aligners, and expansion of iTero scanner sales. Additionally, strategic partnerships, geographic expansion, and investments in digital platforms contribute to the segment's 6% growth.

7. Detailed Products

Invisalign Clear Aligners

A series of custom-made, clear, removable aligners that gradually move teeth into their desired position.

Invisalign Go

A simplified, express version of Invisalign Clear Aligners for mild orthodontic cases.

iTero Element Intraoral Scanner

A digital impression system that captures detailed 3D images of teeth and gums.

Itero Element Flex

A portable, handheld intraoral scanner for dental impressions and oral examinations.

OrthoCAD Digital Orthodontic Treatment Planning

A software platform for orthodontists to plan and visualize treatment outcomes.

8. Align Technology, Inc.'s Porter Forces

Forces Ranking

Threat Of Substitutes

Align Technology, Inc. has a low threat of substitutes due to its unique and patented technology in the orthodontic and dental industries.

Bargaining Power Of Customers

The bargaining power of customers is medium as Align Technology, Inc. has a diverse customer base, but some large customers may have negotiating power.

Bargaining Power Of Suppliers

The bargaining power of suppliers is low as Align Technology, Inc. has a diversified supply chain and is not heavily dependent on a single supplier.

Threat Of New Entrants

The threat of new entrants is low due to the high barriers to entry in the orthodontic and dental industries, including regulatory hurdles and significant capital requirements.

Intensity Of Rivalry

The intensity of rivalry is medium as Align Technology, Inc. operates in a competitive market, but has a strong market position and differentiated products.

9. SWOT Analysis

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 3.37%
Debt Cost 3.95%
Equity Weight 96.63%
Equity Cost 12.26%
WACC 11.98%
Leverage 3.49%

11. Quality Control: Align Technology, Inc. passed 6 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Penumbra

A-Score: 5.0/10

Value: 0.4

Growth: 8.2

Quality: 7.3

Yield: 0.0

Momentum: 8.0

Volatility: 6.0

1-Year Total Return ->

Stock-Card
CONMED

A-Score: 4.8/10

Value: 6.4

Growth: 6.4

Quality: 5.9

Yield: 3.0

Momentum: 2.0

Volatility: 5.0

1-Year Total Return ->

Stock-Card
iRhythm Technologies

A-Score: 4.6/10

Value: 4.2

Growth: 6.1

Quality: 3.1

Yield: 0.0

Momentum: 10.0

Volatility: 4.0

1-Year Total Return ->

Stock-Card
Globus Medical

A-Score: 4.4/10

Value: 3.8

Growth: 6.3

Quality: 7.5

Yield: 0.0

Momentum: 2.5

Volatility: 6.0

1-Year Total Return ->

Stock-Card
Bio-Rad

A-Score: 3.8/10

Value: 6.4

Growth: 2.3

Quality: 5.9

Yield: 0.0

Momentum: 3.0

Volatility: 5.0

1-Year Total Return ->

Stock-Card
Align Technology

A-Score: 3.3/10

Value: 3.6

Growth: 5.3

Quality: 7.5

Yield: 0.0

Momentum: 1.0

Volatility: 2.7

1-Year Total Return ->

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

157.21$

Current Price

157.21$

Potential

-0.00%

Expected Cash-Flows